Atlas Trials

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema

Clinical trial NCT01882712 · WITHDRAWN

Trial details

NCT number
NCT01882712
Sponsor
Galderma R&D
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Erythema
Primary completion
2015-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.